Peer-reviewed articles

Haugh C, Walter S, Sweeney P, McDevitt J, Murray D, Redaniel MT. Socioeconomic differences in prostate cancer diagnosis and stage following the introduction of Rapid Access Prostate Clinics in Ireland. ESMO Real World Data Digit Oncol. 2026;14:100781. doi:10.1016/j.esmorw.2026.100781

Gatta G, Capocaccia R, Rossi S, et al. Cancer Patients Mortality From Other Causes: A European Population-Based Study. Cancer Med. 2026;15(9):e72266. doi:10.1002/cam4.72266

Brennan A, McDevitt J, Heidarian Miri H, et al. Impact of the COVID-19 pandemic on cancer incidence, stage, mortality, and short-term survival in Ireland: a population-based analysis. ESMO Real World Data Digit Oncol. 2026;13:100767. doi:10.1016/j.esmorw.2026.100767

Lopez-Cortes A, Al-Mahdy A, Jakab Z, et al. Correction to: International variation in child healthcare practices and implications for childhood cancer diagnosis: a scoping review and cross-country clinician survey. Eur J Pediatr. 2026;185(8):587. doi:10.1007/s00431-026-07238-1

Bosetti C, Visser O, Van Eycken L, et al. Availability of Stage Information From Cancer Registries Providing Data to the European Cancer Information System for Six Selected Cancers. Int J Cancer. Published online June 15, 2026. doi:10.1002/ijc.70593

Lopez-Cortes A, Al-Mahdy A, Jakab Z, et al. International variation in child healthcare practices and implications for childhood cancer diagnosis: a scoping review and cross-country clinician survey. Eur J Pediatr. 2026;185(7). doi:10.1007/s00431-026-07109-9

He J, Sabroso-Lasa S, Coscia C, et al. A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study. Cancer Epidemiol Biomarkers Prev. 2026;35(6):1009-1018. doi:10.1158/1055-9965.EPI-25-1601

Morgan E, Bardot A, Langselius O, et al. International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study. Lancet Oncol. 2026;27(6):738-750. doi:10.1016/S1470-2045(26)00089-6

Fink H, Soerjomataram I, Bardot A, et al. International comparisons of survival after recurrent metastatic breast cancer in four countries: A population-based study. The Breast. 2026;87:104778. doi:10.1016/j.breast.2026.104778

Deac O, Redaniel MT, McDevitt J, et al. Real-world insights into young-onset gastroesophageal adenocarcinoma: an all-Ireland population-based cancer registry analysis. ESMO Gastrointestinal Oncology. 2026;12:100325. doi:10.1016/j.esmogo.2026.100325

Espina C, Ritchie D, Riboli E, et al. European Code Against Cancer 5th edition: 14 ways you can help prevent cancer. Lancet Reg Health Eur. 2026;63:101592. doi:10.1016/j.lanepe.2026.101592

Cardoso R, Ola I, Jansen L, et al. Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study. Lancet Reg Health Eur. 2026;62:101574. doi:10.1016/j.lanepe.2025.101574

Allemani C, Di Carlo V, Ssenyonga N, et al. Progress towards the WHO Global Initiative for Childhood Cancer target of 60% 5-year survival for all childhood cancers combined, 1990–2019 (CONCORD-4): a Cancer Survival Index derived for 68 countries by analysis of individual records for 613 021 children from 307 population-based cancer registries. The Lancet. Published online March 2026:S0140673626001893. doi:10.1016/S0140-6736(26)00189-3

Botta L, Didonè F, Lopez-Cortes A, et al. Stage at Diagnosis and International Survival Variation in Childhood Tumors in the BENCHISTA Study. JAMA Netw Open. 2026;9(2):e2556747. doi:10.1001/jamanetworkopen.2025.56747

Langtry A, Rabadan R, Alonso L, et al. Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Nat Commun. 2026;17(1):1216. doi:10.1038/s41467-026-69055-2

Gatta G, Luttmann S, Trama A, et al. Corrigendum to “Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival” Eur J Cancer 229 (October) (2025) 115692. European Journal of Cancer. 2026;232:116147. doi:10.1016/j.ejca.2025.116147

Grimes DR, Brennan A, Walsh C. A method of estimating cervical cancers prevented by the introduction of national screening in Ireland. Eur J Public Health. Published online December 19, 2025:ckaf225. doi:10.1093/eurpub/ckaf225

Crocetti E, Bennett D, Jooste V, et al. Skin melanoma survival is improving in Europe but regional differences persist: Results of the EUROCARE-6 study. European Journal of Cancer. 2025;231:116061. doi:10.1016/j.ejca.2025.116061

Langtry A, Rabadan R, Alonso L, et al. Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis. Nat Commun. 2025;16(1):10769. doi:10.1038/s41467-025-65811-y

Allemani C, Minicozzi P, Morawski B, et al. Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories. The Lancet. 2025;406(10517):2325-2348. doi:10.1016/S0140-6736(25)01383-2

Trama A, Rossi S, Bennet D, et al. Corrigendum to “Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based study” [Eur. J. Cancer 2025 Aug 26;226:115535. PMID: 40743655]. Eur J Cancer. 2025;229:115767. doi:10.1016/j.ejca.2025.115767

McCabe M, Rossi S, Cerza F, et al. Survival of European adolescents and young adults diagnosed with central nervous system tumours and comparison with younger and older age groups: EUROCARE-6 results. Eur J Cancer. 2025;227:115661. doi:10.1016/j.ejca.2025.115661

Trama A, Rossi S, Bennet D, et al. Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based study. Eur J Cancer. 2025;226:115535. doi:10.1016/j.ejca.2025.115535

Gatta G, Luttmann S, Trama A, et al. Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival. Eur J Cancer. 2025;229:115692. doi:10.1016/j.ejca.2025.115692

Botta L, Capocaccia R, Bernasconi A, et al. The impact of cancer survivors’ extra risk of non-cancer mortality on net survival estimation. Am J Epidemiol. Published online August 19, 2025:kwaf148. doi:10.1093/aje/kwaf148